BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gellings PS, Wilkins AA, Morici LA. Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine. Pathogens 2020;9:E1066. [PMID: 33352688 DOI: 10.3390/pathogens9121066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Carcione D, Siracusa C, Sulejmani A, Migliavacca R, Mercato A, Piazza A, Principe L, Clementi N, Mancini N, Leoni V, Intra J. In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples. Antibiotics (Basel) 2021;10:1309. [PMID: 34827247 DOI: 10.3390/antibiotics10111309] [Reference Citation Analysis]
2 Avery TM, Boone RL, Lu J, Spicer SK, Guevara MA, Moore RE, Chambers SA, Manning SD, Dent L, Marshall D, Damo SM, Townsend SD, Gaddy JA. Analysis of Antimicrobial and Antibiofilm Activity of Human Milk Lactoferrin Compared to Bovine Lactoferrin against Multidrug Resistant and Susceptible Acinetobacter baumannii Clinical Isolates. ACS Infect Dis 2021;7:2116-26. [PMID: 34105954 DOI: 10.1021/acsinfecdis.1c00087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Sehree MM, Abdullah HN, Jasim AM. Comparison of phenotypic and genotypic assays of biofilm formation in A. baumannii isolates based on gold standard method and related antibiotic resistance. Gene Reports 2022. [DOI: 10.1016/j.genrep.2022.101575] [Reference Citation Analysis]
4 Swietnicki W. Secretory System Components as Potential Prophylactic Targets for Bacterial Pathogens. Biomolecules 2021;11:892. [PMID: 34203937 DOI: 10.3390/biom11060892] [Reference Citation Analysis]
5 Akbari Z, Rasooli I, Ghaini MH, Chaudhuri S, Farshchi Andisi V, Jahangiri A, Ramezanalizadeh F, Schryvers AB. BauA and Omp34 surface loops trigger protective antibodies against Acinetobacter baumannii in a murine sepsis model. International Immunopharmacology 2022;108:108731. [DOI: 10.1016/j.intimp.2022.108731] [Reference Citation Analysis]
6 Magda M, Bettoni S, Laabei M, Fairley D, Russo TA, Riesbeck K, Blom AM. Clinical Isolates of Acinetobacter spp. Are Highly Serum Resistant Despite Efficient Recognition by the Complement System. Front Immunol 2022;13:814193. [DOI: 10.3389/fimmu.2022.814193] [Reference Citation Analysis]
7 Badmasti F, Habibi M, Firoozeh F, Fereshteh S, Bolourchi N, Goodarzi NN. The combination of CipA and PBP-7/8 proteins contribute to the survival of C57BL/6 mice from sepsis of Acinetobacter baumannii. Microb Pathog 2021;158:105063. [PMID: 34166729 DOI: 10.1016/j.micpath.2021.105063] [Reference Citation Analysis]
8 Njeri DK, Ragains JR. Total Synthesis of an All-1,2-cis-Linked Repeating Unit from the Acinetobacter baumannii D78 Capsular Polysaccharide. Org Lett 2022. [PMID: 35522755 DOI: 10.1021/acs.orglett.2c01034] [Reference Citation Analysis]
9 Tansho-Nagakawa S, Sato Y, Ubagai T, Kikuchi-Ueda T, Kamoshida GO, Nishida S, Ono Y. Histopathological Analysis of Acinetobacter baumannii Lung Infection in a Mouse Model. Pol J Microbiol 2021;70:469-77. [PMID: 35003278 DOI: 10.33073/pjm-2021-044] [Reference Citation Analysis]
10 Wei R, Yang X, Liu H, Wei T, Chen S, Li X. Synthetic Pseudaminic-Acid-Based Antibacterial Vaccine Confers Effective Protection against Acinetobacter baumannii Infection. ACS Cent Sci 2021;7:1535-42. [PMID: 34584955 DOI: 10.1021/acscentsci.1c00656] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ud-Din M, Albutti A, Ullah A, Ismail S, Ahmad S, Naz A, Khurram M, Haq MU, Afsheen Z, Bakri YE, Salman M, Shaker B, Tahir Ul Qamar M. Vaccinomics to Design a Multi-Epitopes Vaccine for Acinetobacter baumannii. Int J Environ Res Public Health 2022;19:5568. [PMID: 35564967 DOI: 10.3390/ijerph19095568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]